News & Analysis on Clinical Trial Services & Contract Research And Development
Innovata has entered into a second agreement in which the development of a combination asthma therapy could generate in excess of £25 million (€37 million) in milestones and development funding.
Covalent Group has improved its financial position on last year, reporting a net revenue increase of 45 per cent for the third quarter of 2005 with sales of $2.7 million, (€2.3 million) compared to $1.9 million one year ago.
UK's MedPharm has received a Department of Trade and Industry (DTI) grant for Research and Development to produce its new spray treatment for eczema, expected to be available in the US by 2009.
Contract research organisations (CROs) are responding to the looming threat of competition from India and China by moving outside their traditional role of simply providing contract services to drug companies.
CombiMatrix Molecular Diagnostics (CMD) are to collaborate with the University Of California (UCLA), on a gene-based melanoma laboratory test, which if successful, could result in the development of a clinical molecular test that will more accurately...
Samson Medical Technologies has signed a co-marketing agreement with Baxa for its novel packaging system designed to improve patient safety by reducing the risk of medication errors in prescription drug compounding.
Pharmaceutical companies and manufacturers are increasingly moving to adopt software services that prevent revenue leakage and regulatory compliance exposure.
Generex Biotechnology announced its Oral-lyn, the first non-injectable form of recombinant human insulin available for commercial distribution anywhere in the world is being launched in Ecuador to soon become available through physician referrals.